Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Accumulated Expenses (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Accumulated Expenses for 5 consecutive years, with $1.8 million as the latest value for Q3 2018.

  • Quarterly Accumulated Expenses rose 52.93% to $1.8 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Sep 2018, up 52.93% year-over-year, with the annual reading at $1.0 million for FY2017, 17.32% up from the prior year.
  • Accumulated Expenses hit $1.8 million in Q3 2018 for Armata Pharmaceuticals, up from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.8 million in Q3 2018 to a low of $10000.0 in Q3 2016.
  • Historically, Accumulated Expenses has averaged $719294.1 across 5 years, with a median of $728000.0 in 2015.
  • Biggest five-year swings in Accumulated Expenses: plummeted 97.96% in 2016 and later skyrocketed 11350.0% in 2017.
  • Year by year, Accumulated Expenses stood at $457000.0 in 2014, then surged by 59.3% to $728000.0 in 2015, then grew by 22.94% to $895000.0 in 2016, then grew by 17.32% to $1.0 million in 2017, then skyrocketed by 66.76% to $1.8 million in 2018.
  • Business Quant data shows Accumulated Expenses for ARMP at $1.8 million in Q3 2018, $1.4 million in Q2 2018, and $965000.0 in Q1 2018.